257 related articles for article (PubMed ID: 16274249)
1. Concanamycin and indolyl pentadieneamide inhibitors of the vacuolar H+-ATPase bind with high affinity to the purified proteolipid subunit of the membrane domain.
Whyteside G; Meek PJ; Ball SK; Dixon N; Finbow ME; Kee TP; Findlay JB; Harrison MA
Biochemistry; 2005 Nov; 44(45):15024-31. PubMed ID: 16274249
[TBL] [Abstract][Full Text] [Related]
2. Interaction of inhibitors of the vacuolar H(+)-ATPase with the transmembrane Vo-sector.
Páli T; Whyteside G; Dixon N; Kee TP; Ball S; Harrison MA; Findlay JB; Finbow ME; Marsh D
Biochemistry; 2004 Sep; 43(38):12297-305. PubMed ID: 15379568
[TBL] [Abstract][Full Text] [Related]
3. Interaction of spin-labeled inhibitors of the vacuolar H+-ATPase with the transmembrane Vo-sector.
Dixon N; Páli T; Kee TP; Ball S; Harrison MA; Findlay JB; Nyman J; Väänänen K; Finbow ME; Marsh D
Biophys J; 2008 Jan; 94(2):506-14. PubMed ID: 17872954
[TBL] [Abstract][Full Text] [Related]
4. Membrane-bound peptides from V-ATPase subunit a do not interact with an indole-type inhibitor.
Hesselink RW; Fedorov A; Hemminga MA; Prieto M
J Pept Sci; 2008 Apr; 14(4):383-8. PubMed ID: 18069732
[TBL] [Abstract][Full Text] [Related]
5. Binding assays of inhibitors towards selected V-ATPase domains.
Fernandes F; Loura LM; Fedorov A; Dixon N; Kee TP; Prieto M; Hemminga MA
Biochim Biophys Acta; 2006 Nov; 1758(11):1777-86. PubMed ID: 16996024
[TBL] [Abstract][Full Text] [Related]
6. Structural bases of physiological functions and roles of the vacuolar H(+)-ATPase.
Ma B; Xiang Y; An L
Cell Signal; 2011 Aug; 23(8):1244-56. PubMed ID: 21397012
[TBL] [Abstract][Full Text] [Related]
7. V-ATPase membrane sector associates with synaptobrevin to modulate neurotransmitter release.
Di Giovanni J; Boudkkazi S; Mochida S; Bialowas A; Samari N; Lévêque C; Youssouf F; Brechet A; Iborra C; Maulet Y; Moutot N; Debanne D; Seagar M; El Far O
Neuron; 2010 Jul; 67(2):268-79. PubMed ID: 20670834
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the indole class of vacuolar H(+)-ATPase inhibitors with lipid bilayers.
Fernandes F; Loura L; Koehorst RB; Dixon N; Kee TP; Hemminga MA; Prieto M
Biochemistry; 2006 Apr; 45(16):5271-9. PubMed ID: 16618115
[TBL] [Abstract][Full Text] [Related]
9. Purification of vacuolar ATPase with bafilomycin C1 affinity chromatography.
Rautiala TJ; Koskinen AM; Väänänen HK
Biochem Biophys Res Commun; 1993 Jul; 194(1):50-6. PubMed ID: 8333864
[TBL] [Abstract][Full Text] [Related]
10. Association of the eukaryotic V1VO ATPase subunits a with d and d with A.
Thaker YR; Hunke C; Yau YH; Shochat SG; Li Y; Grüber G
FEBS Lett; 2009 Apr; 583(7):1090-5. PubMed ID: 19289121
[TBL] [Abstract][Full Text] [Related]
11. Topology, glycosylation and conformational changes in the membrane domain of the vacuolar H+-ATPase a subunit.
Kartner N; Yao Y; Bhargava A; Manolson MF
J Cell Biochem; 2013 Jul; 114(7):1474-87. PubMed ID: 23296946
[TBL] [Abstract][Full Text] [Related]
12. Organellar H(+)-ATPase--site directed mutagenesis and suppressor mutants.
Perzov N; Spekova L; Supek F; Nelson H; Nelson N
Acta Physiol Scand Suppl; 1998 Aug; 643():185-94. PubMed ID: 9789560
[TBL] [Abstract][Full Text] [Related]
13. Iejimalides show anti-osteoclast activity via V-ATPase inhibition.
Kazami S; Muroi M; Kawatani M; Kubota T; Usui T; Kobayashi J; Osada H
Biosci Biotechnol Biochem; 2006 Jun; 70(6):1364-70. PubMed ID: 16794315
[TBL] [Abstract][Full Text] [Related]
14. A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.
Adam JL; Briggs MW; McCance DJ
Virology; 2000 Jul; 272(2):315-25. PubMed ID: 10873774
[TBL] [Abstract][Full Text] [Related]
15. Functional properties of a hybrid vacuolar H(+)-ATPase in Saccharomyces cells expressing the Nephrops 16-kDa proteolipid.
Harrison MA; Jones PC; Kim YI; Finbow ME; Findlay JB
Eur J Biochem; 1994 Apr; 221(1):111-20. PubMed ID: 8168500
[TBL] [Abstract][Full Text] [Related]
16. Interaction of dibutyltin-3-hydroxyflavone bromide with the 16 kDa proteolipid indicates the disposition of proton translocation sites of the vacuolar ATPase.
Hughes G; Harrison MA; Kim YI; Griffiths DE; Finbow ME; Findlay JB
Biochem J; 1996 Jul; 317 ( Pt 2)(Pt 2):425-31. PubMed ID: 8713068
[TBL] [Abstract][Full Text] [Related]
17. VMA11 and VMA16 encode second and third proteolipid subunits of the Saccharomyces cerevisiae vacuolar membrane H+-ATPase.
Hirata R; Graham LA; Takatsuki A; Stevens TH; Anraku Y
J Biol Chem; 1997 Feb; 272(8):4795-803. PubMed ID: 9030535
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of the V-ATPase inhibitors concanamycin and indole pentadiene in lipid membranes. Spin-label EPR studies.
Páli T; Dixon N; Kee TP; Marsh D
Biochim Biophys Acta; 2004 May; 1663(1-2):14-8. PubMed ID: 15157605
[TBL] [Abstract][Full Text] [Related]
19. Concanamycin A, the specific inhibitor of V-ATPases, binds to the V(o) subunit c.
Huss M; Ingenhorst G; König S; Gassel M; Dröse S; Zeeck A; Altendorf K; Wieczorek H
J Biol Chem; 2002 Oct; 277(43):40544-8. PubMed ID: 12186879
[TBL] [Abstract][Full Text] [Related]
20. A site-directed cross-linking approach to the characterization of subunit E-subunit G contacts in the vacuolar H+-ATPase stator.
Jones RP; Durose LJ; Phillips C; Keen JN; Findlay JB; Harrison MA
Mol Membr Biol; 2010 Aug; 27(4-6):147-59. PubMed ID: 20446876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
